CTIC: CTI BioPharma Corp. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

CTI BioPharma Corp.

NASDAQ:CTIC

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$9.09
Loss Chance
58.0%
1.86JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Amgen
NASDAQ:AMGN
6.24
$339.30
38.98%
BioMarin Pharmaceutical
NASDAQ:BMRN
6.13
$54.09
4.72%
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.36
$31.26
42.69%
Ironwood Pharmaceuticals
NASDAQ:IRWD
4.38
$3.92
14.25%
Neurocrine Biosciences
NASDAQ:NBIX
7.23
$156.70
36.91%
Jitta Factors
Growth Opportunity (35)
Recent Business Performance (75)
Financial Strength (30)
Return to Shareholders (13)
Competitive Advantage (31)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.86
100.00%
2.34
229.72%
2.34
229.72%
COMPANY DESCRIPTION
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an an oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTI BioPharma Corp. has license and collaboration agreement with Teva Pharmaceutical Industries Ltd. and S*BIO Pte Ltd. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington. As of June 26, 2023, CTI BioPharma Corp. operates as a subsidiary of Swedish Orphan Biovitrum AB (publ).
www.ctibiopharma.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.